Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J., Jan….
Certara improves software capabilities by expanding into deep learning and data fabric PRINCETON, N.J., Jan….
BOSTON, Jan. 04, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
CTIM-76 nominated as Claudin 6 x CD3 bispecific antibody clinical candidate Encouraging endometrial and breast…
PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
Mr. Jordt brings over 25 years of industry experience in corporate strategy and business development…
Owen Hughes appointed Executive Chairman of the Board of Directors and Brad Sitko joins as Chief…
Registration Stability Batch for VP-102 Completed and Placed on Stability Process Validation Batches Successfully Manufactured…
GAITHERSBURG, Md., Jan. 04, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical…
Salud Pharma to launch product in Colombia, Panama, and Costa Rica WINNIPEG, Manitoba, Jan. 04,…
Alcyone’s ThecaFlex DRx™ System is an implantable medical device in development for intrathecal drug delivery CAMBRIDGE,…
― FTX-6058 granted Fast Track Designation for sickle cell disease (SCD) from FDA in December…
REDWOOD CITY, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS),…
Robert J. Gould, Ph.D., former president and founding chief executive officer of Fulcrum, is appointed…
SAN FRANCISCO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage…
RESEARCH TRIANGLE PARK, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
NEW HAVEN, Conn., Jan. 04, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
PowerPlan, Inc., a leading provider of financial software and solutions for the energy industry, today…
Illumio is a Zero Trust Segmentation platform SUNNYVALE, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) —…
Caden is reinventing personal data gathering, measurement, and addressability via an ethically built platform that…
First-of-its-kind features dramatically simplify installation, functionality and mass deployment of 3D perception systems IRVINE, Calif.,…